72 results
8-K
ADAP
Adaptimmune Therapeutics Plc
29 Apr 20
Other Events
8:06am
such as social distancing and the wearing of masks to minimize risk of transmission of COVID-19.
Adaptimmune is doing everything possible to assist the clinical … for manufacture of cell therapies, treatment of patients and certain critical research and development activities. The requirement to stay at home or to social
8-K
EX-14.1
ADAP
Adaptimmune Therapeutics Plc
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
or other controlled substances. The use of illegal drugs or other controlled substances in the workplace is prohibited.
XV. SOCIAL MEDIA
Employees … are expected to use good judgment when using social media and to ensure that their activities are consistent with the Company’s policies, including
10-K
EX-10.20
3l6to h0x2yu92
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
5mx9l nmhwnumm9n52
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.3
vjf09y99
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
qzmott
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.4
xcu82l927 h22b
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-99.1
3hg5 tgioxqrdy6wg
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.2
49bk2pnrn3wwucf597
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
10-K
EX-10.19
w4shftm9f6bl9s2x8k8
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
ahg3z2qsdycx20 4f5
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
c0lc5pf
16 Dec 20
Departure of Directors or Certain Officers
5:01pm